Ocera Therapeutics misses by $0.01, beats on revenue

|About: Ocera Therapeutics, Inc. (OCRX)|By:, SA News Editor

Ocera Therapeutics (NASDAQ:OCRX): Q2 EPS of -$0.46 misses by $0.01.

Revenue of $0.03M beats by $0.01M.